Cargando…
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)
While pharmacotherapy and psychosocial interventions are recommended as the primary frontline treatment for attention deficit hyperactivity disorder (ADHD), alternative approaches to managing ADHD are becoming increasingly popular among patients and their families. Supplementation with polyunsaturat...
Autores principales: | Banaschewski, Tobias, Belsham, Brendan, Bloch, Michael H, Ferrin, Maite, Johnson, Mats, Kustow, James, Robinson, Sarah, Zuddas, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291899/ https://www.ncbi.nlm.nih.gov/pubmed/29921155 http://dx.doi.org/10.1177/0260106018772170 |
Ejemplares similares
-
Twin and Sibling Studies Using Health Insurance Data: The Example of Attention Deficit/Hyperactivity Disorder (ADHD)
por: Langner, Ingo, et al.
Publicado: (2013) -
Efficacy and Safety of Polyunsaturated Fatty Acids Supplementation in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials
por: Händel, Mina Nicole, et al.
Publicado: (2021) -
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Banaschewski, Tobias, et al.
Publicado: (2018) -
Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD)
por: Schmidt, Sören, et al.
Publicado: (2009) -
Emotional dysregulation and attention deficit hyperactivity disorder (ADHD)
por: Turkia, I. Ben, et al.
Publicado: (2021)